SCHEMBL13653516

SCHEMBL13653516

CCOP(=O)(CCNC(=O)c1ccccc1O)OCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAAA Q02083 1/20 0.57
▸ MEN1 O00255 5/20 0.51
▸ KMT2A Q03164 5/20 0.51
▸ POLB P06746 1/20 0.51
▸ HTT P42858 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ HPGD P15428 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ NLRP1 Q9C000 1/20 0.50
▸ HCRTR1 O43613 2/20 0.49
▸ ESRRG P62508 1/20 0.48
▸ KDM4E B2RXH2 4/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15702169 0.79 NAAA (0.63) NAAAMEN1KMT2APOLBHTT
SCHEMBL1238119 0.78 NAAA (0.76) NAAAMEN1KMT2APOLBHTT
SCHEMBL31119121 0.78 HTT (0.69) NAAAMEN1KMT2APOLBHTT
SCHEMBL31119120 0.78 HTT (0.69) NAAAMEN1KMT2APOLBHTT
SCHEMBL5707054 0.78 HTT (0.69) NAAAMEN1KMT2APOLBHTT
SCHEMBL1754811 0.77 NAAA (0.64) NAAAMEN1KMT2APOLBHTT
SCHEMBL8346286 0.76 HTT (0.67) NAAAMEN1KMT2APOLBHTT
Hydrochloric Acid SCHEMBL15769882 0.76 HTT (0.67) NAAAMEN1KMT2APOLBHTT
SCHEMBL3148607 0.75 NAAA (0.88) NAAAMEN1KMT2APOLBHTT
SCHEMBL3077901 0.75 KMT2A (0.67) NAAAMEN1KMT2APOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247488-A1 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS CANNIZZARO CARINA 2009-10-01 — — US disclosed
US-20090247488-A1 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS CANNIZZARO CARINA 2009-10-01 — — US disclosed
US-7432261-B2 Anti-inflammatory phosphonate compounds GILEAD SCIENCES, INC. (US) 2008-10-07 — — US disclosed
US-7432261-B2 Anti-inflammatory phosphonate compounds GILEAD SCIENCES, INC. (US) 2008-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247488-A1 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS PHOSPHO1, TNF, PTGES NAAA 624/4885MEN1 4122/4885KMT2A 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback